Narcolepsy treatment: pharmacological and behavioral strategies in adults and children

Narcolepsy is a disabling, rare, and chronic sleep disorder, currently classified as distinct central nervous system hypersomnia in narcolepsy type 1 (NT1) and narcolepsy type 2 (NT2). Although today a reliable pathogenic hypothesis identifies the cause of NT1 as an autoimmune process destroying hyp...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Sleep & breathing Ročník 24; číslo 2; s. 615 - 627
Hlavní autori: Franceschini, Christian, Pizza, Fabio, Antelmi, Elena, Folli, Maria Claudia, Plazzi, Giuseppe
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: Cham Springer International Publishing 01.06.2020
Springer Nature B.V
Predmet:
ISSN:1520-9512, 1522-1709, 1522-1709
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Popis
Shrnutí:Narcolepsy is a disabling, rare, and chronic sleep disorder, currently classified as distinct central nervous system hypersomnia in narcolepsy type 1 (NT1) and narcolepsy type 2 (NT2). Although today a reliable pathogenic hypothesis identifies the cause of NT1 as an autoimmune process destroying hypocretin-producing cells, there is no cure for narcolepsy, and the symptomatic pharmacological available treatments are not entirely effective for all symptoms. Behavioral therapies play a synergistic role in the disease treatment. We here review the available therapeutic options for narcolepsy, including symptomatic pharmacological treatments as well as behavioral and psychosocial interventions that could help clinicians improve the quality of life of patients with narcolepsy in adulthood and childhood.
Bibliografia:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ISSN:1520-9512
1522-1709
1522-1709
DOI:10.1007/s11325-019-01894-4